Paperkast is a link-aggregator website for academic article discussion.
Please visit our about page for more information!
  1. 2
  1.  

  2. 2

    According to intravitreal injection studies we should use 3+PRN regimen in the patients with ME secondary to BRVO but to our study there are no significant differences in the anatomical or functional results are found between 3+PRN and 1+PRN regimens in the patients receiving ranibizumab for ME secondary to BRVO. So could 3+PRN protocol be deception to increase drug use?